Serum Pro-Gastrin-Releasing Peptide Is a Useful Marker for Treatment Monitoring and Survival in Small-Cell Lung Cancer

Publisher： Karger

E-ISSN： 1423-0232|57|2|143-148

ISSN： 0030-2414

Source： Oncology, Vol.57, Iss.2, 1999-08, pp. : 143-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Demonstration and Diagnostic Significance of Pro-Gastrin-Releasing Peptide in Medullary Thyroid Carcinoma

By  

Oncology, Vol. 59, Iss. 2, 2000-08 ,pp. : 122-125

Karger

Access to resources Recommend Favorite

Identification of binding sites for C‐terminal pro‐gastrin‐releasing peptide (GRP)‐derived peptides in renal cell carcinoma: a potential target for future therapy

By  

BJU INTERNATIONAL, Vol. 115, Iss. 5, 2015-05 ,pp. : 829-838

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pro-Brain Natriuretic Peptide is a Sensitive Marker for Detecting Cardiac Metastases in Patients with Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 32, Iss. 7, 2009-06 ,pp. : 389-392

Karger

Access to resources Recommend Favorite

Topotecan in the First-Line Treatment of Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 23, Iss. 3, 2000-05 ,pp. : 13-17

Karger

Access to resources Recommend Favorite

Gastrin-Releasing Peptide Receptor Expression in Cervical Cancer

By  

Oncology, Vol. 73, Iss. 5-6, 2008-05 ,pp. : 340-345

Karger

Access to resources Recommend Favorite